The properdin system and immunity. III. The zymosan assay of properdin.
about
A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION.Chronic hemolytic anemia due to cold agglutinins: the mechanism of resistance of red cells to C' hemolysis by cold agglutinins.Functional role of antibody against "core" glycolipid of Enterobacteriaceae.Immunoglobulin M-dependent classical complement pathway activation in killing of Pentatrichomonas hominis.The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria.Inactivation of endotoxin by a humoral component. VI. Two separate systems required for viable and killed Salmonella typhosa.Triggering Dectin-1-Pathway Alone Is Not Sufficient to Induce Cytokine Production by Murine Macrophages.The properdin system in transplantable cancer (Gardner lymphosarcoma 6C3HED).The growth and death of wound bacteria in serum, exudate and sloughIncreased resistance to infection and accompanying alteration in properidin levels following administration of bacterial lipopolysaccharides.Elevation of properdin levels in mice following administration of bacterial lipopolysaccharidesQuantitative studies on the properdin-complement system. II. Kinetics of the reaction between properdin and zymosan.The properdin system and immunity. VII. Alterations in properdin levels and resistance to infection in mice following the administration of tissue polysaccharides.Studies on the mechanism of hypersensitivity phenomena. II. The participation of complement in passive cutaneous anaphylaxis of the albino rat.Studies on infection and immunity in experimental typhoid fever. II. Susceptibility of recovered animals to re-exposure.Studies on immune cellular injury. I. Cytotoxic effects of antibody and complement.Studies on immune human hemolysis. I. The kinetics of the Donath-Land-steiner reaction and the requirement for complement in the reaction.A HEMOLYTIC SYSTEM ASSOCIATED WITH ENTERITIS IN RABBITS : I. NATURE OF THE CELL CHANGE AND THE SERUM FACTORS CONCERNED.Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement.Purification and immunological characterization of types 4 and 5 adenovirus-soluble antigensPneumococcal intracellular killing is abolished by polysaccharide despite serum complement activity.Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellaeNEUTRALIZATION OF BACTERIOPHAGE BY THE PROPERDIN SYSTEM.Recent advances in cutaneous candidiasis.Effect of proflavine on the synthesis of adenovirus, type 5, and associated soluble antigens.Differential effect of hog gastric mucin on properdin and host resistance to infection.Serum-red cell interactions at low ionic strength: erythrocyte complement coating and hemolysis of paroxysmal nocturnal hemoglobinuria cellsA simple method to detect complement receptors using baker's yeast: Y C rosettes.Isolation of a hagfish gene that encodes a complement component.The role of properdin in the alternate pathway of complement activation.The properdin system and immunity. V. The bactericidal activity of the properdin system.STUDIES ON IMMUNE HUMAN HEMOLYSIS : II. THE DONATH-LANDSTEINER REACTION AS A MODEL SYSTEM FOR STUDYING THE MECHANISM OF ACTION OF COMPLEMENT AND THE ROLE OF C'1 AND C'1 ESTERASE.Changes in vascular permeability produced in rats by dextran, ovomucoid and yeast cell wall polysaccharides.Loa loa Microfilariae evade complement attack in vivo by acquiring regulatory proteins from host plasma.Binding of Soluble Yeast β-Glucan to Human Neutrophils and Monocytes is Complement-Dependent.The mononuclear phagocytes of the rat adrenal.The properdin system and immunity. VI. The inactivation of Newcastle disease virus by the properdin system.Studies on the biologic relationship of endotoxin and other toxic proteins. I. Comparison of the properties of snake venom and endotoxin.The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man.Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A Streptococci. II. Human plasma cofactor (s) enhancing opsonization of encapsulated organisms.
P2860
Q34005453-B2B4B825-50AF-4BA2-A8D9-5645F4CDF9D6Q34086742-952C533D-0734-461B-A70C-CBDE77E1CB99Q34482763-0DA91307-4938-4521-A0E2-DD95ACEC9A11Q35092738-BD9BD327-CFF5-43E9-99F8-5D578482F8F4Q35299988-E7767335-D9C8-412F-A22D-811E76E38CD7Q35564585-AACC86AF-BDB9-4C14-ACED-11C0BD043A86Q35913499-9A604C27-BDC8-40F0-A9DC-581EA4E1B4FDQ35916505-7560700A-F981-4E8F-99C2-A15B30ACCD1BQ36258741-29413F0D-E692-4C14-BE59-F56FBB301108Q36262965-111162E5-00D9-45C1-AD1A-A2214AE7AD54Q36263069-9090525A-3E64-484F-9398-2B8461C82F7DQ36263449-3CB32D9B-E68D-437C-B34E-0D71EC7F1665Q36263499-613D5E78-C2B1-41EF-915C-83F73131A872Q36263773-56C27860-1227-4429-A01C-41ADF6972A42Q36265160-CE623DD3-30EA-4B99-9BFE-1B692C6223AFQ36265183-85811BB6-3139-4FE0-9FAB-06AF286EFA4AQ36265241-2B7F8BFB-0886-4EB9-8ABA-6E9AA6A7CB7EQ36266231-657D44DB-BF42-4B49-9350-683C18394DF1Q36384714-BD3F6838-D909-4751-ABD7-1A47B5DE4EA0Q36407268-2420FC3F-C6B2-47CE-8F75-1EE9AEDD3E5CQ37014223-FD56393B-9E0B-4992-A991-E3FC6485FED7Q37107256-852076CD-A708-4CCA-A1C9-A98AB9A3BE3FQ37688046-EE84692B-D20B-4F15-8E5E-E7931D741956Q39782815-BF8FC9C0-9033-4571-96E2-679F78C45397Q40252601-9E8A3358-299A-4E76-9C72-3792C4BBE88EQ40315470-D0101C06-2C27-480E-8DE9-0CCF15E93B93Q40349200-16DC7B9F-CAF7-4A9F-839F-C063B3E00D5CQ40999144-88C3DD20-7751-4F82-9AA8-B45F64E38C5CQ41517982-983A8413-1650-438E-8BE6-B1B74F5562EBQ41845152-285627A3-FEC7-4B9B-9A11-23D8C773A4AFQ41962116-AEAE0CA0-B852-4E4E-B02E-59BCC731B398Q42155624-640D9ED3-6B59-464C-BDED-A833C37032D1Q42371462-0CB0F020-E9E8-41BA-BC33-797B0546BE31Q42546078-4AB34945-808E-47A5-88A1-678E0581B88DQ42549855-A7152B1F-756B-4BB8-8484-8EA4E2DABD50Q42735347-99224A40-5774-4100-B81B-758D481E1F3BQ42822247-6E333D17-A3EF-42CC-AC7F-109DCC9FF430Q42826808-FE1F2801-5405-4AE1-A64A-BDE3BB14D40FQ42835089-6957A4A0-D71A-4813-90FD-AF653B5E43E1Q42927001-D99E1753-54A3-43C6-BF21-42393B4ADEE8
P2860
The properdin system and immunity. III. The zymosan assay of properdin.
description
1956 nî lūn-bûn
@nan
1956年の論文
@ja
1956年論文
@yue
1956年論文
@zh-hant
1956年論文
@zh-hk
1956年論文
@zh-mo
1956年論文
@zh-tw
1956年论文
@wuu
1956年论文
@zh
1956年论文
@zh-cn
name
The properdin system and immunity. III. The zymosan assay of properdin.
@en
type
label
The properdin system and immunity. III. The zymosan assay of properdin.
@en
prefLabel
The properdin system and immunity. III. The zymosan assay of properdin.
@en
P2093
P356
P1476
The properdin system and immunity. III. The zymosan assay of properdin.
@en
P2093
P2860
P356
10.1084/JEM.103.1.1
P407
P577
1956-01-01T00:00:00Z